Study questions FDA warning over adverse cognitive effects of statins In 25 placebo-controlled trials involving nearly 47,000 patients, adverse cognitive outcomes attributable to statins were rarely reported, researchers found.…
Eculizumab — with £340,200 price tag — gets go ahead from NICEEculizumab, dubbed “the world’s most expensive drug”, is being made available on the NHS in England following guidance from the National Institute for Health and Care Excellence.…
Drug manufacturers propose alert system to mitigate medicine shortages European drug manufacturers have developed a communications framework which they claim could help prevent medicines shortages or lessen their impact.…
Older patients taking anticholinergic drugs are at risk of dementia People aged over 65 years who take some common over-the-counter or prescribed medicines for allergy, depression or an overactive bladder have an increased risk of developing dementia.…
EMA recommends suspending licences for 700 drugs over flawed analyses by GVK BiosciencesThe European Medicines Agency is recommending that the marketing authorisation be suspended for more than 700 generic products tested by GVK Biosciences.…
Latest advances in hepatitis C therapy The availability of new protease inhibitors is revolutionising the treatment of hepatitis C virus infection.…
Use of NSAIDs associated with surgery complication Use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients undergoing surgery may be associated with anastomotic leak at the surgical junction, research confirms.…
Human Protein Atlas reveals drug targets The Human Protein Atlas shows the locations of almost 17,000 different proteins in the human body and could offer invaluable guidance for drug developers. …
EU approval of AbbVie’s hepatitis C combination therapies challenges Gilead’s Harvoni A highly effective therapy for patients with hepatitis C is being launched by AbbVie in the EU over the next couple of months in direct competition with another treatment made by Gilead that was approved in 2014 and is now being rolled out. …
US President launches ‘precision medicine’ initiative Precision medicine got a shot in the arm on 20 January 2015, when US President Barack Obama launched a Precision Medicine Initiative to help cure diseases like cancer and diabetes.…